Overview
- 233 inspections across 225 sites are on record.
- 604 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-08-06.
At a glance
Inspections
233
Sites
225
Observations
604
Career since
Jul 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| B. Braun US Pharmaceutical Manufacturing, LLC | 6 Aug 2024 | Biologics | |
| Vitalant | 15 Feb 2024 | Biologics | |
| CSL Plasma, Inc. | 16 Dec 2022 | Biologics | |
| Vitalant | 26 Apr 2022 | Biologics | |
| La Vita Compounding Pharmacy, LLC | 11 Mar 2020 | Human Drugs | View 483 → |
Sites inspected
B. Braun US Pharmaceutical Manufacturing, LLCIrvine, United States1 insp.
VitalantLittleton, United States1 insp.
CSL Plasma, Inc.Arvada, United States1 insp.
VitalantParker, United States1 insp.
La Vita Compounding Pharmacy, LLCSan Diego, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Jeffrey B Moody8 shared
Ka L Wong6 shared
Binh T Nguyen5 shared
Ademola O Daramola5 shared
Natalie J Ayoub5 shared
Christopher M Jenner4 shared
Zachery L Miller4 shared
Zachary L Stamm4 shared
Nayan J Patel4 shared
Michele L Obert4 shared
Full investigator report
Get the verbatim findings behind Zachary A Bogorad's 604 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site